A

s Brexit nears and the European Medicines Agency prepares to move its headquarters from London, the regulator warned it could lose gobs of employees and, depending upon the new location, may no longer be able to function. But even the loss of just 15 percent of its staff would require at least a two-year recovery.

The dire forecast, which emerged from a survey of approximately 900 EMA employees, found more than 70 percent of the staff would leave if the agency relocated to eight of 19 cities that are being considered for its new headquarters. Under this scenario, the agency warned such an exodus would have “important consequences for public health in the European Union.”

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • If I worked in London, I would want to go somewhere comparable culturally. So this is not only unsurprising, it seems bluntly obvious without needing a survey for confirmation.
    why does it need to be monolithic? Couldn’t some functions be done in different locations? What about working remotely (for some)?

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.